Skip to main content

Go Premium in Our Biggest Sale Ever

UPGRADE NOW
TipRanks
Go Ultimate75% OFF

HK:1276 Stock Latest News

Company AnnouncementsHengrui Pharma Receives NMPA Approval for Rivocibart Injection1d ago1276
Hengrui Pharma Seals Up to US$2.6 Billion Global Licensing Deal With Novo Nordisk for Oral GLP-1/GIP DrugCompany AnnouncementsHengrui Pharma Seals Up to US$2.6 Billion Global Licensing Deal With Novo Nordisk for Oral GLP-1/GIP Drug1M ago1276
Company AnnouncementsHengrui Pharma Clears All Resolutions at 2026 Extraordinary Shareholders’ Meeting1M ago1276
Company AnnouncementsHengrui Wins NMPA Approval for New Uses of Innovative Thrombocytopenia Drug2M ago1276
Hengrui Pharma Advances 2026 Employee Stock Ownership Plan Using Existing A SharesCompany AnnouncementsHengrui Pharma Advances 2026 Employee Stock Ownership Plan Using Existing A Shares2M ago1276
Company AnnouncementsJiangsu Hengrui Proposes 2026 H Share Incentive Scheme to Strengthen Governance2M ago1276
Company AnnouncementsJiangsu Hengrui Pharmaceuticals Announces Resignation of Joint Company Secretary2M ago1276
Hengrui Pharma Wins First China Approval for Home-Grown Long-Acting Insulin AnalogCompany AnnouncementsHengrui Pharma Wins First China Approval for Home-Grown Long-Acting Insulin Analog3M ago1276
Company AnnouncementsHengrui Wins NMPA Nod to Move Cervical Cancer Combo to First-Line Use3M ago1276
Company AnnouncementsHengrui Pharma Wins NMPA Approval for First 0.1% Water-Free Cyclosporine Eye Drop in China4M ago1276